A Phase II Study of AL-37807 to Treat Open-Angle Glaucoma or Ocular Hypertension

Alcon Research120 enrolled

Overview

The purpose of this study is to determine whether AL-37807 is safe and effective in treating patients with open-angle glaucoma or ocular hypertension

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

DOUBLE

Enrollment

120

Conditions

Open-Angle Glaucoma Ocular Hypertension

Interventions

AL-37807DRUG

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Adult patients of either sex and any race with open-angle glaucoma or ocular hypertension; logMAR visual acuity not worse than 0.60; additionally clinically relevant ophthalmic or systemic conditions may be excluded Exclusion Criteria: * Under 18

Locations (1)

San Antonio Site

San Antonio, Texas, United States

Outcomes

Primary Outcomes

Mean IOP change from baseline

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.